tirzepatide and iih Trial for Idiopathic Intracranial Hypertension FDA approves tirzepatide, Eli Lilly's

While its not FDA approved for weight loss, it can be prescribed off-label for that purpose

This suggests that the GLP-1R KO mouse model may serve as a model for correlated metabolic and functional connectivity loss

If I need to, if I feel like I need to get back on it after kids, I will." This approach aligns with her understanding of obesity treatment: "I went into this knowing this was a long-term solution, that it was a long-term medication for maintenance, and I'm perfectly okay with that." Treating Obesity as a Chronic Condition "My obesity is a chronic illness, and these medications are revolutionary," Carolyn affirms

Based on publicly available FDA records of the warning letters issued in September 2025 and February/March 2026, Eden's name does not appear among the companies that received warning letters in those enforcement rounds